title: Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation.
authors.affiliation: Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.
authors.forename: E J
authors.initials: EJ
authors.lastname: Shpall
authors.forename: I C
authors.initials: IC
authors.lastname: Anderson
authors.forename: R C
authors.initials: RC
authors.lastname: Bast
authors.forename: W T
authors.initials: WT
authors.lastname: Joines
authors.forename: R B
authors.initials: RB
authors.lastname: Jones
authors.forename: M
authors.initials: M
authors.lastname: Ross
authors.forename: S
authors.initials: S
authors.lastname: Edwards
authors.forename: S
authors.initials: S
authors.lastname: Eggleston
authors.forename: C
authors.initials: C
authors.lastname: Johnston
authors.forename: M
authors.initials: M
authors.lastname: Tepperberg
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001853:Bone Marrow / Q000187:drug effects / Q000276:immunology; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation / Q000379:methods*; D001943:Breast Neoplasms / Q000628:therapy*; D003114:Colony-Forming Units Assay; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000031:analogs & derivatives / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008280:Magnetics; D008863:Microspheres; D014182:Transplantation, Autologous; D014407:Tumor Cells, Cultured
chemical_list: D000911:Antibodies, Monoclonal; D003520:Cyclophosphamide; C011272:perfosfamide